Alopecia clinical trials in Ohio
4 studies for Alopecia are looking for participants at sites in Ohio.
Cities in Ohio
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
- Bexley Dermatology Research, Bexley
- Cincinnati Childrens Hospital Medical Center, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Nov 4, 2026 · NCT05723198Phase 2/3 Efficacy and Safety of PP405 in Adult Males
- Bexley Dermatology Research/Dermatologists of Southwestern Ohio, Bexley
- Optima Research Boardman, Boardman
- Dermatologists of Southwest Ohio, LLC, Mason
RecruitingPhase 2/3
Ages 18 to 55 · Men · Updated Oct 28, 2026 · NCT07819435A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Bexley Dermatology Research, Bexley
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Oct 20, 2026 · NCT06873945HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
- The Ohio State University Wexner Medical Center, Columbus
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Sep 15, 2026 · NCT07049328From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.